Drugs that contain Atazanavir Sulfate; Cobicistat
1. Evotaz patents expiration
EVOTAZ's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5849911 | BRISTOL | Antivirally active heterocyclic azahexane derivatives |
Jun, 2017
(6 years ago) | |
| US6087383 | BRISTOL | Bisulfate salt of HIV protease inhibitor |
Dec, 2018
(5 years ago) | |
| US8148374 | BRISTOL | Modulators of pharmacokinetic properties of therapeutics |
Sep, 2029
(5 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5849911 (Pediatric) | BRISTOL | Antivirally active heterocyclic azahexane derivatives |
Dec, 2017
(6 years ago) | |
|
US6087383 (Pediatric) | BRISTOL | Bisulfate salt of HIV protease inhibitor |
Jun, 2019
(4 years ago) | |
| US10039718 | BRISTOL | Use of solid carrier particles to improve the processability of a pharmaceutical agent |
Oct, 2032
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Aug 27, 2017 |
NCE-1 date: 27 August, 2016
Market Authorisation Date: 29 January, 2015
Treatment: Method for treating hiv-1 infection; Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase
Dosage: TABLET;ORAL
How can I launch a generic of EVOTAZ before it's drug patent expiration?
More Information on Dosage
EVOTAZ family patents
